Therapies: Progressive steps

被引：0
|
作者：
Elie Dolgin
机构：
[1] Elie Dolgin is a science writer based in Somerville,
[2] Massachusetts.,undefined
来源：
Nature | 2016年 / 540卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
New drugs are beginning to show promise for people with one of the less common, and harder to treat, forms of multiple sclerosis.
引用
下载
收藏
页码：S7 / S9
相关论文
共 50 条
  • [41] Local Solutions to Inequality: Steps Toward Fostering a Progressive Social Movement
    Bailey, Conner
    RURAL SOCIOLOGY, 2013, 78 (04) : 411 - 428
  • [42] Progressive steps in the development of electron backscatter diffraction and orientation imaging microscopy
    Dingley, D
    JOURNAL OF MICROSCOPY-OXFORD, 2004, 213 : 214 - 224
  • [43] Stem cell regenerative therapies for neonatal diseases: Small steps, time to leap?
    Young, Karen C.
    SEMINARS IN PERINATOLOGY, 2023, 47 (03)
  • [44] Targeted Therapies for Hereditary Peripheral Neuropathies: Systematic Review and Steps Towards a 'treatabolome'
    Jennings, Matthew J.
    Lochmuller, Angela
    Atalaia, Antonio
    Horvath, Rita
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (03) : 383 - 400
  • [45] Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
    Thompson, Rachel
    Bonne, Gisele
    Missier, Paolo
    Lochmueller, Hanns
    EMERGING TOPICS IN LIFE SCIENCES, 2019, 3 (01) : 19 - 37
  • [46] Evaluation of medical therapies in the nursing home population: Gaps, challenges, and next steps
    Unroe, Kathleen T.
    Saliba, Debra
    Hickman, Susan E.
    Zimmerman, Sheryl
    Levy, Cari
    Gurwitz, Jerry
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 (09) : 2951 - 2956
  • [47] Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies
    Alcala, C.
    Gascon, F.
    Perez-Miralles, F-C.
    Escutia, M.
    Coret, F.
    Casanova, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 702 - 702
  • [48] Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
    Eric M. L. Williamson
    Joseph R. Berger
    Neurotherapeutics, 2017, 14 : 961 - 973
  • [49] Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
    Hatchwell, Eli
    Smith, Edward B. B.
    Jalilzadeh, Shapour
    Bruno, Christopher D. D.
    Taoufik, Yassine
    Hendel-Chavez, Houria
    Liblau, Roland
    Brassat, David
    Martin-Blondel, Guillaume
    Wiendl, Heinz
    Schwab, Nicholas
    Cortese, Irene
    Monaco, Maria Chiara
    Imberti, Luisa
    Capra, Ruggero
    Oksenberg, Jorge R. R.
    Gasnault, Jacques
    Stankoff, Bruno
    Richmond, Todd A. A.
    Rancour, David M. M.
    Koralnik, Igor J. J.
    Hanson, Barbara A. A.
    Major, Eugene O. O.
    Chow, Christina R. R.
    Eis, Peggy S. S.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [50] Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies
    Williamson, Eric M. L.
    Berger, Joseph R.
    NEUROTHERAPEUTICS, 2017, 14 (04) : 961 - 973
12345